Posts Tagged ‘industry’

Fluidigm to present state-of-the-art single-cell genomics technology, Nov. 8

The Fluidigm Corporation will be presenting on their single-cell genomics technology; an overview of the field of single-cell genomics and examples of applications on Friday, November 8 from 10 to 11 a.m. in Mac Hall 3189. This technology is currently deployed in the lab of Dr. Lincoln Shenje of the Knight Cardiovascular Institute. This research capability is made possible by the generous donation from the Knight Family, and this is one of the numerous ways in … Read More

Brown bag seminar: How to Pitch to Industry, Oct. 22

When pitching to the Pharma and Biotech industry, developing an effective strategy to create new, long-lasting partnerships can be difficult. The office of Technology Transfer & Business Development (TTBD) offers insight to align your expertise, resources and partnering philosophies to connect with a wide variety of companies in the industry. Join us for a brown bag presentation and Q&A on “How to Pitch to Industry” led by Abhijit Banerjee, director of Business Development and Joseph … Read More

Knight Cancer Institute showcased by Intel president at tech conference

As reported in Knight News, Intel President Renee James recently highlighted Intel’s collaboration with OHSU to advance personalized cancer medicine during her keynote address at the 2013 Intel Developer Forum in San Francisco on September 10. At about 15 minutes into her speech, James plays a video that shows a number of familiar faces and includes interviews with Brian Druker, M.D., and Joe Gray, Ph.D. After the keynote, Paul Spellman, Ph.D., was also interviewed for … Read More

Sigma Life Science presents innovative technologies symposium, Aug. 21

Sigma-Aldrich will be hosting a symposium in the OHSU Auditorium on Wednesday, August 21 from 9 a.m. to 12 p.m. The half-day symposium will focus on Sigma Life Science technologies and capabilities for the characterization of biological systems. Topics will include RNAi and microRNA-based approaches for target identification and validation, along with Zinc Finger Nuclease technology and CRISPR. To view an agenda or register, visit sigma.com/symposia-northwest. The symposium’s keynote speaker, Dr. Keming Song, is a … Read More

New: OHSU Tech Transfer & Business Development quarterly newsletter

Find out about all of the latest happenings in Tech Transfer and Business Development at OHSU in the new quarterly TTBD newsletter. Highlights include: The Guide to Technology Transfer and Business Development – A handy online document outlining how our office can assist you Important patent law changes – What is the America Invents Act and how does that relate to patents at OHSU? Success story – Neuro Kinetics Inc. has licensed software from OHSU … Read More

Novo Nordisk Diabetes and Obesity Award; applications due May 1

OHSU has been selected by Novo Nordisk to participate in the Novo Nordisk Diabetes and Obesity Biologics Science Forum Awards. Twenty institutions from the western region have been invited to participate. The objective of this program is to help US scientists substantiate and translate early innovation research efforts and clarify if their hypotheses could result in new treatment options for diabetes and obesity. The awards are for non-clinical research related to new biologic therapeutics and … Read More

National SBIR/STTR conference comes to Portland, Nov. 13-15

The Micro-enterprise Inventors Program of Oregon (MIPO) and the Oregon Small Business Development Center Network (OSBDC) will host the 2012 National Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Conference at the Doubletree Hotel Lloyd Center in Portland from November 13 to 15. This conference will provide critical information to researchers and small businesses competing for SBIR/STTR grants and contracts, which amount to approximately $2.5 billion annually.  SBIR and STTR are competitive federal government programs … Read More

Mouse model developed at OHSU leads to breakthrough in malaria research

In 2007, OHSU’s Markus Grompe, M.D., and collaborators, developed an animal model for studying a human-specific parasite that causes malaria. Just recently, this mouse model was used by investigators at Seattle Biomedical Research Institute to gain a better understanding of how proteins are expressed in the liver during infection. Their research was published online in the Journal of Clinical Investigation. The technology was licensed to Yecuris Corporation back in 2007, a biotech company founded by … Read More

Funding available from Genentech

Genentech, a biotech company with offices in Hillsboro, Oregon, is looking to fund research projects, health-related programs and events, and fellowships related to the following therapeutic areas: Genentech funds general research, translational research, other research or development projects, and other initiatives of research organizations, labs, and academic institutions. Genentech also supports programs and events such as: patient services, patient outreach, patient education, disease education, fundraisers, health screenings, scientific/medical meetings, conferences, seminars and symposia. Applications are … Read More

Novo Nordisk diabetes research funding opportunity, due Aug. 1

Novo Nordisk R&D has renewed its research award program which helps new and established scientists substantiate early innovation in the area of diabetes and obesity research. Areas of research supported by the awards include (1) new biologic therapeutics and targets amenable to biologics therapeutics or novel effects of known biologics in the field of Type 1 Diabetes and Type 2 Diabetes, including microvascular complications and obesity, and (2) protein-based science technologies including oral and injection … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives